Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Alexion Pharmaceuticals Inc.
Current Parent Company: AstraZeneca
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $21,000,000
Year: 2020
Date: July 2, 2020
Offense Group: competition-related offenses
Primary Offense: Foreign Corrupt Practices Act
Secondary Offense: financial institution supervision failures
Violation Description: The SEC found that two Alexion subsidiaries made payments to foreign government officials to secure favorable treatment for Alexion's drug Soliris.
Level of Government: federal
Action Type: agency action
Agency: Securities and Exchange Commission
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.